Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 5—May 2022
Research Letter

Increased COVID-19 Severity among Pregnant Patients Infected with SARS-CoV-2 Delta Variant, France

Souheil Zayet, Vincent Gendrin, Catherine Gay, Philippe Selles, and Timothée KlopfensteinComments to Author 
Author affiliation: Nord Franche-Comté Hospital, Trevenans, France

Main Article

Figure

Monthly cases of hospitalized, severe, and critical COVID-19 cases among women of childbearing age (15–42 years) and pregnant women at Nord Franche-Comté Hospital, France, March 1, 2020–November 15, 2021. We assessed COVID-19 disease severity against circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants during 3 periods of interest based on predominance of circulating variants. During period 1, wild-type virus comprised >50% of all sequenced SARS-CoV-2 variants in France; during period 2, >50% were Alpha variant; and during period 3, >50% were Delta variant. COVID-19, coronavirus disease; ICU, intensive care unit.

Figure. Monthly cases of hospitalized, severe, and critical COVID-19 cases among women of childbearing age (15–42 years) and pregnant women at Nord Franche-Comté Hospital, France, March 1, 2020–November 15, 2021. We assessed COVID-19 disease severity against circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants during 3 periods of interest based on predominance of circulating variants. During period 1, wild-type virus comprised >50% of all sequenced SARS-CoV-2 variants in France; during period 2, >50% were Alpha variant; and during period 3, >50% were Delta variant. COVID-19, coronavirus disease; ICU, intensive care unit.

Main Article

Page created: February 16, 2022
Page updated: April 19, 2022
Page reviewed: April 19, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external